A study published by researchers from the Fred Hutchinson Cancer Research Center in Seattle has found that admission to the intensive care unit reduced survival and increased the cost of care among patients undergoing treatment for acute myeloid leukemia.
A study published by researchers from the Fred Hutchinson Cancer Research Center in Seattle has found that admission to the intensive care unit (ICU) reduced survival and increased the cost of care among patients undergoing treatment for acute myeloid leukemia (AML).
A disease with dismal outcomes, about 75% of patients diagnosed with AML do not survive for more than 5 years. With the objective of examining the risk factors, mortality, length of stay (LOS), and cost associated with admission to the ICU for patients with AML, scientists at Fred Hutch extracted data from the University HealthSystem Consortium database on adult patients diagnosed with AML and who were hospitalized between January 1, 2004, and December 21, 2012. The primary outcomes being evaluated were admission to the ICU and inpatient mortality among patients who needed ICU care. Secondary outcomes included LOS in ICU, total LOS, and cost.
During the study period, a little more than 25% (11,277) of patients diagnosed with AML were admitted to the ICU. Risk factors for admissions included:
In-hospital mortality was significantly greater in patients who needed ICU care (4857 of 11,277 [43.1%] vs 2959 of 31,972 [9.3%]). The authors identified the following risk factors for death in the ICU-admitted cohort:
Simultaneous with the increased ICU admission was the increased cost of care—patients who needed the intensive care treatment incurred nearly double the cost of those who were not in the ICU ($83,354 versus $41,973, respectively). Presence of comorbidities further accentuated treatment costs, from $50,543 for no comorbidities, all the way to $124,820 in patients with at least 5 comorbidities.
The authors conclude that while comorbidities increase the risk of mortality and cost of care in patients with AML, appropriate interventions by identifying patients at high risk for ICU use could reduce fatalities.
Reference
Halpen AB, Culakova E, Walter RB, Lyman GH. Association of risk factors, mortality, and care costs of adults with Acute Myeloid Leukemia with admission to the intensive care unit [published online November 10, 2016]. JAMA Oncol. doi: 10.1001/jamaoncol.2016.4858.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More